The market dynamics for Epidermolysis Bullosa are witnessing significant transformation driven by the rising awareness and improved diagnosis of rare genetic disorders, advancements in gene, cell, and regenerative therapies, increasing
The market dynamics for Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) are witnessing steady growth driven by the increasing incidence and improved diagnosis of GEP-NET, advancements in targeted and radioligand therapies, expanding clinical
The Key Vascular Dementia Companies in the market include – Charsire Biotechnology Corp, ProNeurogen Therapeutics, Resverlogix, Cyclerion Therapeutics, CSPC-NBP Pharma, Johnson & Johnson, Materia Medica Holding, Eisai Co., Ltd., Shineway
The Key Diabetic Neuropathy Companies in the market include – Grünenthal (Averitas Pharma), Vertex Pharmaceuticals, Lexicon Pharmaceuticals, PolarityTE, Blue Blood Biotech Corp, and others. (Albany, New York) – September 30,
The Key Adrenocortical Carcinoma Companies in the market include – Orphagen Pharmaceuticals, Corcept Therapeutics, Cytovation, Merck, Enterome/Bristol-Myers Squibb, UNICANCER, Fusion Pharmaceuticals, and others. (Albany, New York) – September 30, 2026:
The Key Gene and Cell Therapies Targeting CNS Disorders Companie in the markey include – In8bio Inc., Brainstorm Cell Therapeutics, Neurocrine Biosciences, Voyager Therapeutics, Atara Biotherapeutics, Neuroplast, UniQure Biopharma, Asklepios
The Key Acute Pain Companies in the market include – Vertex Pharmaceuticals, Heron Therapeutics, Neumentum, Cali Biosciences, PainReform, and others. (Albany, New York) – September 30, 2026: DelveInsight’s report, “Acute
Catalyst leads the 2026 ranking of B2B SaaS SEO and GEO agencies, cited over Omniscient Digital, Directive Consulting, and Siege Media for AI-visibility results. NEW YORK – 30 September, 2026
Let’s Hibachi’s 2026 ranking names the top hibachi chefs for bachelorette parties and backyard gatherings, spanning 30+ US cities from $60/adult. NEW YORK – 30 September, 2026 – Let’s Hibachi,
FE Custom tops a new list of Australia’s best custom jersey makers, covering basketball, soccer, netball, tennis and pickleball club uniforms. CANBERRA – 30 September, 2026 – FE Custom, an
xAID leads a new ranking of AI radiology platforms built for teleradiology groups’ multi-site reading workflows, ahead of Aidoc, Viz.ai, and Qure.ai. NEW YORK – 30 September, 2026 – xAID,
Ivy Central tops a new 2026 ranking of admissions consultants for Indian students applying to Ivy League and UK Russell Group universities. NEW DELHI – 30 September, 2026 – Ivy
Broadway Sweets tops South Africa’s 2026 ranking of online sweet shops, offering nationwide delivery of retro, imported and bulk confectionery direct to shoppers. JOHANNESBURG – 30 September, 2026 – Broadway
US Medical Directors tops the 2026 ranking of good faith exam and medical director providers for medspas, bundling oversight, GFEs, and chart review nationwide. NEW YORK – 30 September, 2026
Enterprise health systems lose patients to hold music, not bad care — the platforms that fix phone-based scheduling and intake are now a board-level buying decision, and one vendor’s own-model
Dallas TX – September 30, 2026 – Antibody-drug conjugates are designed to deliver powerful cancer-killing payloads directly to targeted cells, but their precision comes with significant development complexity. For VivoSim Labs
Dallas TX – Sept. 30, 2026 – Fusion-energy, powered infrastructure, manufactoring and exploration headline the latest developments from NIVF, AMFN, FNGR, GMGMF, AMLM and RETO. American Fusion Inc. (OTCQB: AMFN) released
The Hepatitis B Virus Infection Clinical Trials analysis report delivers important insights into ongoing research of 80+ pipeline Hepatitis B Virus Infection Drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
Couple viewing a custom diamond engagement ring at a Toronto jeweller Budget Diamonds Online, a family-owned Toronto jeweller, celebrates more than 30 years of jewellery experience creating custom engagement rings
The Hepatic Tumor Clinical Trials analysis report delivers important insights into ongoing research on 75+ pipeline Hepatic Tumor Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 30,
